| Patient | Robert Peary |
|---|---|
| Date of birth | 1963-05-06 |
| Identifiers | MRN HR-EX004-SYN; SSN (made up) 000-04-7351 |
| Document date | 2026-01-21 |
| Author | Thaddeus Lindgren-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Eight-day review with the reticulocyte response, seen the same day by hematology. [S]
Admiral Peary returns eight days after starting cyanocobalamin and is seen by Dr. Abernethy-Kwan of hematology on the same day. He has had five of the seven loading injections, given by the clinic nurse every other day. His tongue is less sore and he has a little more energy, though he is still breathless on the stairs. The numbness and pins and needles in his feet are unchanged; he has had no falls, and he checks his feet each morning. He has had no palpitations, muscle cramps or weakness. His potassium, planned with the second injection, was not drawn then. Blood for intrinsic factor and parietal cell antibodies, gastrin and thyroid antibodies was drawn this morning before his fifth injection. [S]
| Element | Detail |
|---|---|
| Injections | Five of seven loading doses given |
| Symptoms | Tongue better, slightly more energy; breathless on stairs; feet unchanged |
| Reticulocytes | 7.9%, from 0.4% |
| Hemoglobin | 8.9 g/dL, from 8.2 |
| Potassium | 3.6 mmol/L |
| Antibodies | Intrinsic factor antibody 38.5 AU/mL; parietal cell antibody 96.0; gastrin 820 pg/mL; thyroid peroxidase antibody 6 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired, a little better |
| Cardiovascular | Negative | No chest pain or palpitations |
| Respiratory | Positive | Breathless on one flight of stairs |
| Gastrointestinal | Positive | Tongue less sore; no indigestion, black stools or weight loss |
| Neurological | Positive | Numbness and tingling in both feet; no falls |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn | 1,000 micrograms into the muscle every other day, seven doses | Intramuscular route | 2026-01-13 to 2026-01-25 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-21 | Body height | 183 | cm | S |
| 2026-01-21 | Body weight | 72.6 | kg | S |
| 2026-01-21 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 2026-01-21 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-01-21 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-01-21 | Heart rate | 94 | /min | S |
| 2026-01-21 | Respiratory rate | 16 | /min | S |
| 2026-01-21 | Body temperature | 36.6 | Cel | S |
| 2026-01-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-21 | Hemoglobin [Mass/volume] in Blood | 8.9 | g/dL | 13.2-17.1 g/dL | Low | S |
| 2026-01-21 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 114 | fL | 80-100 fL | High | S |
| 2026-01-21 | Leukocytes [#/volume] in Blood by Automated count | 4.6 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 2026-01-21 | Platelets [#/volume] in Blood by Automated count | 186 | 10*3/uL | 140-400 10*3/uL | Normal | S |
| 2026-01-21 | Reticulocytes/Erythrocytes in Blood by Automated count | 7.9 | % | 0.5-2.5% | High | S |
| 2026-01-21 | Potassium [Moles/volume] in Serum or Plasma | 3.6 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 2026-01-21 | Intrinsic factor Ab [Units/volume] in Serum by Immunoassay | 38.5 | [arb'U]/mL | 1.1 AU/mL or less: negative | High | S |
| 2026-01-21 | Parietal cell Ab [Units/volume] in Serum by Immunoassay | 96 | [arb'U]/mL | Below 20.1: negative | High | S |
| 2026-01-21 | Gastrin [Mass/volume] in Serum or Plasma | 820 | pg/mL | <=100 pg/mL | High | S |
| 2026-01-21 | Thyroperoxidase Ab [Units/volume] in Serum or Plasma | 6 | [IU]/mL | <=8 [IU]/mL | Normal | S |
Vital signs recorded on 2026-01-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Pale; slight yellow tinge to the eyes; blood pressure 122/68, pulse 94 |
| Mouth | Tongue smooth but less red |
| Cardiovascular | Soft systolic flow murmur; no edema |
| Neurological | Vibration absent at the ankles and reduced at the knees; joint position sense impaired at both great toes; ankle jerks absent, knee jerks brisk, plantar responses flexor; Romberg positive; gait broad-based and slow |
| Feet | Healed stumps of the second to fifth toes on both feet; callus under the right first metatarsal head; skin intact; pulses present |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fatigue, breathlessness on exertion, pallor with a lemon-yellow tinge, a sore tongue, and numbness and unsteadiness in the feet over about four months, with a macrocytic anemia, low white cells and platelets, a low vitamin B12 and a high methylmalonic acid; cause under evaluation with a hematology consultation | resolved | confirmed | D51.9 | S — Synthetic presenting problem anchored to the documented pernicious anemia of his last years; superseded when the consultation confirmed pernicious anemia. |
| Pernicious anemia (autoimmune gastritis with intrinsic factor antibodies), with severe vitamin B12 deficiency; synthetic modern diagnosis linked to the documented cause of his death | active | confirmed | D51.0 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented death from pernicious anemia; the timing and course in the modern episode are synthetic. |
| Subacute combined degeneration of the spinal cord with peripheral neuropathy from vitamin B12 deficiency: loss of vibration and joint position sense in the feet, absent ankle jerks, brisk knee jerks and a positive Romberg test | active | confirmed | G32.0 | S — Synthetic neurological complication; not a claim about his real nerves. |
| Absence of the second to fifth toes of the right foot after frostbite and amputation in early middle age; healed stumps; callus under the first metatarsal head | active | confirmed | Z89.421 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| Absence of the second to fifth toes of the left foot after frostbite and amputation in early middle age; healed stumps | active | confirmed | Z89.422 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| One fall in a dark bedroom a month ago without injury; unsteady in the dark and on uneven ground; uses a stick outdoors | active | confirmed | Z91.81 | S — Synthetic fall linked to the neuropathy and the old toe amputations. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Symptoms: fatigue, breathlessness, exercise tolerance, sore tongue, numbness | Every visit during active treatment | Completed today | Tongue better and slightly more energy; breathless on stairs; feet unchanged |
| Laboratory | Reticulocyte count | About one week after the first injection | Completed today | 7.9% at day 8, from 0.4%: an appropriate response |
| Laboratory | Blood count with MCV | About eight weeks after starting replacement, with earlier checks in severe anemia | Completed today | Early check in severe anemia: hemoglobin 8.9 g/dL, MCV 114 fL, white cells 4.6, platelets 186 |
| Laboratory | Potassium | In the first days of treatment of severe anemia | Deferred | The potassium planned with the second injection on day 3 was not drawn. Today it is 3.6 mmol/L, at the low end of normal, with no cramps, weakness or palpitations, so no harm is evident. Corrective action: potassium checked at the next visit, and a standing order for potassium added to any future loading course |
| Laboratory | Cause of deficiency: intrinsic factor and parietal cell antibodies, gastrin | At diagnosis | Completed today | Intrinsic factor antibody 38.5 AU/mL and parietal cell antibody 96.0 positive; gastrin 820 pg/mL; drawn before today's injection |
| Laboratory | Autoimmune screening: TSH and thyroid antibodies; HbA1c | At diagnosis of autoimmune gastritis | Completed today | TSH 2.6 and HbA1c 5.5% at intake; thyroid peroxidase antibody 6 IU/mL today, negative |
| Medication safety | Transfusion threshold (restrictive, hemoglobin 7 to 8 g/dL, or symptoms at rest) | While hemoglobin is low | Completed today | Hemoglobin 8.9 g/dL and rising; no chest pain or breathlessness at rest; no transfusion |
| Medication safety | Injection plan: doses given, self-injection technique, site problems | Every visit | Completed today | Five of seven loading doses given; self-injection taught today for the weekly phase |
| Examination | Neurological examination: vibration, joint position, reflexes, Romberg, gait, cognition | At diagnosis and at follow-up visits for six weeks to three months, then until recovery levels off | Completed today | Unchanged from intake |
| Examination | Falls and gait: falls since the last visit, Timed Up and Go, home hazards | Every visit | Completed today | No falls; night lights fitted |
| Examination | Upper endoscopy with Sydney-protocol biopsies for autoimmune gastritis, neuroendocrine tumors and dysplasia | At diagnosis of pernicious anemia; then by individual risk | Ordered | Booked with a screening colonoscopy in four weeks |
| Self-management | Feet: daily skin checks, footwear, callus and stump skin, monofilament | Every visit | Completed today | Daily checks begun; skin intact; callus under the right first metatarsal head |
| Referral | Hematology consultation | At diagnosis | Completed today | Seen by Dr. Abernethy-Kwan today |
| Referral | Podiatry | Within four weeks of intake, then every three months | Ordered | Booked for the second week of February |
| Referral | Physical therapy for balance and gait | From diagnosis until balance recovers | Ordered | Starting next week |
Goal progress:
Guideline basis: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026); Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024)
Follow-up: Last two loading doses with the nurse, then weekly self-injection. Five-week review on the day of the endoscopy and colonoscopy. Call for palpitations, cramps, weakness, a fall, or any wound on the feet. Next scheduled visit 2026-02-17: five-week review on the day of upper endoscopy and colonoscopy: blood count, nerves, falls and feet. [S]